Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2256667 | 0.85 | DUT (0.42) | DUT | |
| SCHEMBL2256200 | 0.83 | DUT (0.41) | DUT | |
| SCHEMBL11580466 | 0.83 | DUT (0.42) | DUT | |
| SCHEMBL740880 | 0.79 | DUT (0.34) | DUT | |
| SCHEMBL8063404 | 0.78 | DUT (0.43) | DUT | |
| SCHEMBL5694164 | 0.78 | DUT (0.33) | DUT | |
| SCHEMBL28538333 | 0.78 | DUT (0.43) | DUT | |
| SCHEMBL3509611 | 0.76 | DUT (0.35) | DUT | |
| SCHEMBL9007756 | 0.76 | DUT (0.42) | DUT | |
| SCHEMBL178549 | 0.76 | DUT (0.35) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534646-A | Preparation method of procyanidine B2 | 朗华生物科学(深圳)有限公司 | 2024-02-09 | — | — | CN | claimed |
| EP-3539968-B1 | NOVEL TRITYL PROTECTING AGENT | SEKISUI MEDICAL CO LTD (JP) | 2021-07-14 | — | — | EP | claimed |
| US-10981940-B2 | Trityl protecting agent | SEKISUl MEDICAL CO., LTD. (JP) | 2021-04-20 | — | — | US | claimed |
| US-20190308997-A1 | NOVEL TRITYL PROTECTING AGENT | SEKISUI MEDICAL CO., LTD. (JP) | 2019-10-10 | — | — | US | claimed |
| EP-3539968-A1 | NOVEL TRITYL PROTECTING AGENT | Sekisui Medical Co., Ltd. (JP) | 2019-09-18 | — | — | EP | claimed |
| US-20240114908-A1 | 2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT | NIPPON SODA CO., LTD. (JP) | 2024-04-11 | — | — | US | disclosed |
| CN-117534646-A | Preparation method of procyanidine B2 | 朗华生物科学(深圳)有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-114585610-A | 2, 6-dioxo-3, 6-dihydropyrimidine compound, and agricultural and horticultural bactericide, nematicide, and medical and animal antifungal agent | 日本曹达株式会社 | 2022-06-03 | — | — | CN | disclosed |
| CN-109963861-B | Novel trityl protective agent | 积水医疗株式会社 | 2021-09-28 | — | — | CN | disclosed |
| EP-3539968-B1 | NOVEL TRITYL PROTECTING AGENT | SEKISUI MEDICAL CO LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-10981940-B2 | Trityl protecting agent | SEKISUl MEDICAL CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190308997-A1 | NOVEL TRITYL PROTECTING AGENT | SEKISUI MEDICAL CO., LTD. (JP) | 2019-10-10 | — | — | US | disclosed |
| EP-3539968-A1 | NOVEL TRITYL PROTECTING AGENT | Sekisui Medical Co., Ltd. (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-9073885-B2 | Vitamin D3 lactone derivatives | TEIJIN PHARMA LIMITED (JP) | 2015-07-07 | — | — | US | disclosed |
| EP-1589009-B1 | VITAMIN D3 LACTONE DERIVATIVE | TEIJIN PHARMA LTD (JP) | 2014-10-08 | — | — | EP | disclosed |
| EP-2363390-A1 | DERIVED LACTAM FROM D3 VITAMIN | Teijin Pharma Limited (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | TEIJIN PHARMA LIMITED (JP) | 2011-08-25 | — | — | US | disclosed |
| US-20060148768-A1 | Vitamin d3 lactone derivatives | TEIJIN LIMITED (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1589009-A1 | VITAMIN D3 LACTONE DERIVATIVE | Teijin Pharma Limited (JP) | 2005-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981940-B2 | Trityl protecting agent | POT1, TXNL1, TXLNA | DUT 4663/4885 |
| US-20060148768-A1 | Vitamin d3 lactone derivatives | VDR, CYP24A1, CYP2R1 | DUT 2761/4885 |
| US-20190308997-A1 | NOVEL TRITYL PROTECTING AGENT | POT1, TXNL1, TXLNA | DUT 4627/4885 |
| US-20240114908-A1 | 2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT | BROX, HPD, DAXX | DUT 26/4885 |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | VDR, CYP24A1, CYP2R1 | DUT 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.